Language  ||  English : Spanish : Arabic  
Home Company Profile Business Opportunity QualityControl Manufacturing Contact Us
clen 50 clenbuterol
Click to enlarge

Clen 50

1 Tab contains:
Clenbuterol Hydrochloride 50mcg
Chemical: 4-amino-alpha-[(tert-butylamino) methyl]-3, 5-dichlorobenzyl alcohol hydrochloride
Molecular Formula: C12H18Cl2N2O
Molecular Weight: 277.19
Chem Structure
Clen 50 contains the long-acting stimulant bronchodilator clenbuterol for oral use. Clenbuterol exerts its effects by agonizing beta-2-adrenergic receptors, resulting in bronchodilation and increased metabolic activity.
Clen 50 is indicated in patients where bronchodilation and potent increases in basal metabolic activity are clinically desirable.
Clen 50 contains clenbuterol hydrochloride for oral use. Clenbuterol is a beta-2-adrenergic agonist relaxing airway muscle tissue and providing bronchodilation. Clenbuterol increases aerobic capacity, pulse, perspiration, and blood pressure; increasing basal metabolic rate and temperature.
Clen 50 exerts a pronounced action on the metabolism; with both anabolic and anti-catabolic effects. Clenbuterol has been demonstrated to increase the rate of protein synthesis in muscle tissue and to increase protein to fat ratio.
Clenbuterol has an oral bioavailability of 89 to 98 percent with a half-life of 36 to 48 hours after oral use.
CNS: Nervousness, tremor, ataxia, dizziness, restlessness, agitation, anxiety, insomnia, and headache;
Cardiovascular: palpitations, tachycardia, hypertension, angina, ventricular extrasystole, myocardial infarction; rarely subaortic stenosis;
Metabolic: Increased basal temperature/pyrexia, diaphoresis and electrolyte disturbances; elevated serum CK; thrombocytopenia, hypoglycaemia, rarely thyrotoxicosis;
Respiratory: paradoxical bronchial spasm;
Other: Urticaria, facial oedema, cramping, relaxation of uterine lining, gastric irritation, nausea, vomiting, increased appetite, dry mouth, constipation, cough and local irritation, difficulty in urination & urinary retention, and hypersensitivity reactions.
Clenbuterol may enhance the action and side effects of other beta-adrenergic mimetics, theophylline, and anti-cholinergics.
Beta-blockers may inhibit the action of clenbuterol; thus a risk of bronchospasm exists with concomitant treatment.
Clenbuterol may alter the action of hypoglycemic agents, insulin sensitizers, insulin, and insulin secretagogues. Adjustment of dosage may be required. Monitor for loss of glycemic control.
There is an increased risk of arrhythmia with concomitant administration of chalogenated carbohydrates for narcosis; e.g. during surgery.
Concomitant use with diuretics and digitalis glycosides requires periodic monitoring of serum electrolytes.
Concomitant use with other CNS stimulants should be avoided given the cumulative stimulatory effects and increased risk of adverse events.
Concomitant use with MAO-inhibitors and tri-cyclic antidepressants may produce cardiac dysrhythmias.
Not for use with children or geriatric patients.
Clenbuterol should not be used by women who are pregnant or may become pregnant.
Not for use in patients with cardiovascular disease, hypertension, or history of cardiovascular events.
Not for use in patients with current or historical myocardial infarction; liver or renal insufficiency; tachycardia, other cardiac dysrhythmias, myocarditis, mitral valve prolapse, hypokalemia or unmanaged diabetes.
Not for use in patients with elevated intraocular pressure, adrenal tumors, or hyperthyroidism.
Not to be used concomitantly with other CNS stimulants, adrenergic, or hypertensive agents.
Not to be used in patients with hypersensitivity to clenbuterol or other ingredients.
Not to be used in patients with a history of GI bleeding, ulceration of the stomach, or gastritis.
Keep out of the reach of children. In case of accidental ingestion, contact a physician immediately.
Clen 50 can produce significant cardiovascular effects in some patients as evidenced by elevated pulse rate, blood pressure changes and/or ECG changes. Clen 50 patients should be monitored for changes in heart rate, arterial blood pressure, and/or oxygen saturation of arterial blood.
Urticaria and tachycardia may be observed during the first few days of treatment; if this occurs; discontinue and consult physician immediately.
Not for use by nursing mothers due to unknown effects from excreted milk.
During initial treatment, increased attention and caution should be exercised when driving or using machinery as clenbuterol may produce tremor and anxiety.
Clenbuterol overdose may be characterized by: tremor of the fingers, significant sweating, headache, and tachycardia. Extreme and severe overdose cases have presented with collapse, seizures, coma, and death. In cases of overdose, clenbuterol use should be discontinued. Stomach lavage with activated charcoal, forced diuresis, and symptomatic therapy should be performed. In doses higher than prescribed, clenbuterol may aggravate existing asthma. In all such cases, seek emergency medical assistance.
As prescribed by physician: Maximum dosage of 1 tablet orally per day.
Uncoated tablets: 100 tablets in blisters.
Protect from light. Store at 15 - 25oC.
  Magnum Pharmaceuticals Authentication

Try our new method to quickly authenticate your product using the 2D barcode.
Click the respective link to download the QR Reader app for your phone.

Android OS | Blackberry OS | iOS | Windows Phone OS

2012 © All Rights Reserved Magnum Pharmaceuticals Co., Ltd.

Please Note : We do not sell or ship to the USA, Europe, Australia or any other locations where prohibited. All information contained within this website or in any literature provided is not a prescription to use. Please seek the advice of a physician specializing in Andrology before use.
Not affiliated with Magnum Pharma (USA), Magnum Pharmaceuticals Inc. (USA), Magnum Chemi-Tech Ltd., or Magnum Nutraceuticals (Asia) Pte Ltd.

Distributors must submit licensing, a company profile, and our completed distributor application for approval prior to ordering.